The company have demonstrably improved the development of a new therapy for cardiac amyloidosis, utilizing the compound. Preliminary patient results suggests promising outcomes for patients affected from this serious https://bridgebio989594.59bloggers.com/42477278/firm-improves-attr-cm-therapy-with-the-drug